An Open Prospective Longitudinal Pulmonary-cardiovascular Cohort Study
Launched by REGION SKANE · Oct 25, 2011
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 45-75 years
About Region Skane
Region Skåne is a leading healthcare authority in Sweden, dedicated to advancing medical research and improving patient care through innovative clinical trials. Committed to fostering collaboration between researchers, healthcare professionals, and patients, Region Skåne aims to enhance the understanding of various health conditions and develop effective treatment strategies. With a focus on ethical standards and patient safety, the organization plays a pivotal role in shaping the future of healthcare in the region and beyond, ensuring that clinical trials are conducted with the highest level of scientific rigor and transparency.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lund, , Sweden
Patients applied
Trial Officials
Louise Hagman Bennet, MD, PhD
Study Chair
Skane University Hospital
David Erlinge, MD, PhD
Principal Investigator
Skane University Hospital
Claes-Göran Löfdahl, MD, PhD
Principal Investigator
Skane University Hospital
Maria Planck, MD, PhD
Principal Investigator
Skane University Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials